KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Equity (2016 - 2025)

Historic Return on Equity for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to 10.32%.

  • Pacific Biosciences Of California's Return on Equity fell 94900.0% to 10.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.32%, marking a year-over-year decrease of 94900.0%. This contributed to the annual value of 0.51% for FY2024, which is 300.0% down from last year.
  • According to the latest figures from Q3 2025, Pacific Biosciences Of California's Return on Equity is 10.32%, which was down 94900.0% from 6.87% recorded in Q2 2025.
  • Pacific Biosciences Of California's 5-year Return on Equity high stood at 0.03% for Q3 2021, and its period low was 10.32% during Q3 2025.
  • For the 5-year period, Pacific Biosciences Of California's Return on Equity averaged around 1.35%, with its median value being 0.46% (2022).
  • Per our database at Business Quant, Pacific Biosciences Of California's Return on Equity skyrocketed by 19500bps in 2021 and then tumbled by -94900bps in 2025.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Return on Equity stood at 0.16% in 2021, then plummeted by -233bps to 0.53% in 2022, then rose by 21bps to 0.42% in 2023, then tumbled by -54bps to 0.65% in 2024, then crashed by -1499bps to 10.32% in 2025.
  • Its Return on Equity was 10.32% in Q3 2025, compared to 6.87% in Q2 2025 and 2.2% in Q1 2025.